Effect of Alemtuzumab on Intestinal Intraepithelial Lymphocytes and Intestinal Barrier Function in Cynomolgus Model-Reference-Cited by-同舟云学术

Effect of Alemtuzumab on Intestinal Intraepithelial Lymphocytes and Intestinal Barrier Function in Cynomolgus Model

Published:2015-03-05 Issue:5 Volume:128 Page:680-686
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Qu Lin-Lin,Lyu Ya-Qing,Jiang Hai-Tao,Shan Ting,Zhang Jing-Bin,Li Qiu-Rong,Li Jie-Shou

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference26 articles.

1. FDA drug approval summary: Alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia;Demko;Oncologist,2008

2. Current and novel therapies in acute GVHD;Ho;Best Pract Res Clin Haematol,2008

3. Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells;Rowan;Immunology,1998

4. Mechanism of action and resistance to monoclonal antibody therapy;Villamor;Semin Oncol,2003

5. Hematology Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Alemtuzumab in chronic lymphocytic leukemia;Fraser;Curr Oncol,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial transcription factor A plays opposite roles in the initiation and progression of colitis‐associated cancer;Cancer Communications;2021-06-23

2. Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know;Brain Sciences;2020-04-14

3. Microbiota-Immune Interaction in the Pathogenesis of Gut-Derived Infection;Frontiers in Immunology;2019-08-07

4. The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics;Brain;2018-05-30

5. Challenges with Intestine and Multivisceral Re-Transplantation: Importance of Timing of Re-Transplantation and Optimal Immunosuppression;Annals of Transplantation;2018-02-06